1. Lipid Accumulation Product
2. Stroke Risk Factors
3. Cardiovascular Health
4. Ischemic Stroke Prevention
5. Kailuan Study Findings

In a major breakthrough, researchers have uncovered critical evidence suggesting that a higher cumulative Lipid Accumulation Product (LAP) can significantly augment the risk of stroke. This landmark investigation, part of the extensive Kailuan Study, meticulously analyzed the long-term implications of continued elevated lipid levels in the body on stroke incidence. The findings, published in the journal Nutrition, Metabolism, and Cardiovascular Diseases, has potential ramifications for millions of at-risk individuals globally. The study is available online with the DOI: 10.1016/j.numecd.2023.12.003.

Background of the Study

Lipid accumulation has long been implicated in the pathogenesis of cardiovascular diseases (CVD). Previous research has identified single measurements of LAP as indicators of increased cardiac risk. However, there remained uncertainty around the effects of sustained high levels of LAP over time and their specific relationship with the incidence of stroke. To address this uncertainty, a comprehensive cohort study was conducted with participants from the Kailuan Study.

Study Parameters and Population

The study encompassed a vast cohort of 43,089 participants who were initially free from any cardiovascular conditions. To assess the cumulative impact of LAP, the average LAP index was multiplied by the time interval between consecutive health examinations, resulting in the creation of four distinct quartile groups based on LAP levels. Higher LAP exposure was defined for participants who recorded LAP values in excess of the 90th percentile for this population during each health assessment.

During an 11-year median follow-up period, 2461 individuals among the cohort developed a stroke, with ischemic strokes being the predominant type (2220 cases), followed by hemorrhagic strokes (320 cases), and 79 cases of concurrent stroke types.

Key Findings and Implications

The research team, led by prominent scholars including Hui Zhou of Central South University and Yulong Lan of Shantou University Medical College, deployed multivariable Cox proportional hazard models to establish the association between cumulative LAP and stroke. After adjusting for subsuming potential confounders, a consistent and gradual risk increase for stroke was seen from the second quartile (Q2) group to the fourth (Q4), with hazard ratios (HRs) rising from 1.19 (95% CI: 1.05-1.36) to a stark 1.50 (95% CI: 1.30-1.70). This heightened risk was predominantly seen in cases of ischemic stroke, with HRs rang from 1.21 (95% CI: 1.06-1.39) in Q2, escalating to 1.56 (95% CI: 1.36-1.79) in Q4.

Notably, hemorrhagic stroke did not exhibit a statistically significant variation in incidence related to LAP levels. Moreover, an extended duration of exposure to heightened LAP was correlated with intensified risk of stroke, buttressing the postulate that long-term LAP levels play a substantial role in determining stroke vulnerability.

This study affirms the pressing need for sustained lipid monitoring and management as part of comprehensive stroke prevention strategies. The research punctuates the dire outcomes associated with long-standing disregard for lipid levels within the body and cements the position of LAP as a critical metric in cardiovascular health evaluation.

Conducting Stratification and Sensitivity Analyses

The strength of the study’s findings is reinforced by thorough stratification and sensitivity analyses, which consistently mirrored the primary outcomes, stating a clear and significant association between cumulative LAP and incident stroke, more so concerning ischemic stroke.

This research adds a dimension to our understanding of lipid management in preventive healthcare, particularly emphasizing the importance of mitigating the LAP index over time, as opposed to relying solely on single-point measurements.

Conclusion and Directions for Future Research

Extensive in scope and meticulous in its methodology, this study signals a shift in how medical practitioners may approach the monitoring of lipid levels and their long-term control in the context of stroke prevention. The Kailuan Study demonstrates that relentless elevations in LAP could be a harbinger for ischemic stroke and underscores the potential benefits of early intervention and sustained lipid management.

The inclusion of scientists such as Shuohua Chen of Kailuan General Hospital, and collaborators from institutions like the Edith Cowan University School of Medical and Health Sciences, points to the collaborative effort involved in this expansive research initiative.

Despite the extensive insights provided, further research is advocated to expand on these outcomes and explore more profound the mechanisms by which cumulative LAP influences stroke pathogenesis. Particularly, more detailed analyses distinguishing the specific characteristics of those at higher risk could enhance targeted preventive strategies.

Moving ahead, healthcare practitioners are encouraged to integrate cumulative LAP evaluation into routine risk assessments for cardiovascular diseases. The principles derived from this study have the potential to inform policy and public health initiatives geared towards the reduction of stroke incidences.


1. Zhou, H., Lan, Y., Wu, D., Chen, S., Ding, X., & Wu, S. (2023). The effect of cumulative lipid accumulation product and related long-term change on incident stroke: The Kailuan Study. Nutrition, Metabolism, and Cardiovascular Diseases.
2. Kahn, H. S. (2005). The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord, 5, 26.
3. Tirosh, A., Shai, I., Afek, A., Dubnov-Raz, G., Ayalon, N., Gordon, B., … Rudich, A. (2011). Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med, 364(14), 1315-1325.
4. The Kailuan Study (n.d.).
5. Writing Group Members et al. (2016). Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association. Circulation, 133(4), e38-360.

Categorized in:

Health News,

Last Update: March 16, 2024